Comment on

• Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.

  Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, Laffel G, Sweitzer BJ, Shea BF, Hallisey R, et al. Bates DW, et al. JAMA. 1995 Jul 5;274(1):29-34. JAMA. 1995. PMID: 7791255
• Systems analysis of adverse drug events. ADE Prevention Study Group.

  Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, Hallisey R, Ives J, Laird N, Laffel G, et al. Leape LL, et al. JAMA. 1995 Jul 5;274(1):35-43. JAMA. 1995. PMID: 7791256